Munetaka Takekuma Kwong K Wong Robert L Coleman
10.1186/s40661-016-0026-5
Gynecol Oncol Res Pract
2016 May 5;3:5.
kras mutation low-grade serous ovarian cancer mek inhibitor selumetinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/27231576/
Case Reports
PMC4880811
27231576
A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib
2016